Research shows increased OMA1 activity and mitochondrial fragmentation in cisplatin-resistant cancer cells, suggesting a mechanism of therapy resistance.
Key Points
Cancer cells surviving cisplatin chemotherapy show increased OMA1 activity, indicating a novel stress response.
Cells that enter a resistant state become larger and non-proliferative, adapting to oxidative stress over time.
Increasing mitochondrial fragmentation limits fusion and function, highlighting a critical survival mechanism in therapy resistance.
Understanding these stress responses may help in targeting cancer cells in future therapies aimed at overcoming resistance.